The Novartis health index: a method for valuing the economic impact of risk reduction in a workforce.
J Occup Environ Med 2010;
52:528-35. [PMID:
20431406 DOI:
10.1097/jom.0b013e3181dbe339]
[Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVES
To develop a calculator that measures the potential cost impact of changes in health risks and presents results graphically.
METHODS
Demographic and health risk data for Novartis employees were input into a calculator that estimated employer medical care, short-term disability, absenteeism, and presenteeism costs associated with risk prevalence, based on a previous cross-sectional analysis of the association between risks and costs. Estimated costs were presented as a relative score, the Novartis Health Index, which is a measure of the overall costs associated with the risk profile of a population of interest.
RESULTS
The population of Novartis employees had an index score of 81.5 (out of 100), indicating a relatively healthy risk profile, and baseline annual costs of $9619 per employee. Risk reduction of 1% and 10% for tobacco, alcohol use, and emotional health risks had the potential to generate annual savings of $91,500 and $915,000, respectively.
CONCLUSIONS
The Novartis Health Index framework allows employers to track performance relative to health risk management using a single, accessible, user-friendly measure.
Collapse